Hims & Hers Stock Is Falling Ahead of Earnings. What to Expect. — Barrons.com
By Janet H. ChoHims & Hers Health stock was falling on Monday ahead of the telehealth company's third-quarter earnings report.Shares were down about 10% at $23.39 in late-afternoon trading on Monday, reversing an 8% gain on Friday, when it announced an agreement with pharmaceutical giant Eli Lilly…
Story updates
09:05:53 PM UTC
SquawkNews
Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE:HIMS), the leading global health and wellness platform, today announced financial results for the third quarter ended September 30, 2026.“In healthcare, whoever owns the customer relationship wins, and that’s exactly what we’re building…